EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY 4.0

MDA5-associated juvenile dermatomyositis and interstitial lung disease from rapidly progressive to silent: a report of three cases in South African children and a review of the literature

Maurane Lepage, Gabriella Pereira, Shehnaaz Akhalwaya, Taryn Gray, Marco Zampoli, Mignon McCulloch, Peter Nourse, Ashton Coetzee, Claire Procter, Khanyisile Hlongwa, Tanyia Pillay, Kate Webb

Clinical Rheumatology · 2026-07 · 45 (7) · 4635-4646

DOI: 10.1007/s10067-026-08070-6 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Rheumatology, online erschienen am 22.04.2026. Verfasst von Maurane Lepage und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Rheumatology, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa. Hauptthemen laut MEDLINE: Dermatomyositis, Lung Diseases, Interstitial, Interferon-Induced Helicase, IFIH1, Autoantibodies. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Cape Town.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Juvenile dermatomyositis (JDM) is a rare pediatric autoimmune disease. A distinct clinical phenotype is associated with anti-melanoma differentiation-associated gene 5 (anti-MDA5) autoantibodies, which are linked to features such as arthritis, ulcerative skin lesions, and a heightened risk of interstitial lung disease (ILD), including its rapidly progressive form (RP-ILD). Despite increased recognition of this phenotype in East Asian, European, and North American populations, significant gaps remain in understanding its pathogenesis, and no consensus has been reached regarding optimal treatment strategies. Moreover, data on anti-MDA5-associated JDM in African populations are nonexistent. Case presentation We report the first three documented cases of anti-MDA5-positive JDM with ILD in African children. All patients exhibited characteristic extramuscular manifestations, and all had pulmonary involvement, which was rapidly progressive in two children, one of whom died. The clinical course, diagnostic findings, and treatment strategies are discussed in the context of existing literature.

Methods

A review of the literature was performed to evaluate the prevalence, clinical presentation, and treatment approaches for RP-ILD in anti-MDA5-associated JDM across different populations.

Conclusion

These cases highlight the wide heterogeneity of clinical phenotypes associated with anti-MDA5 autoantibodies in JDM. Given this variability, individualized monitoring and management strategies are essential to optimize outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DermatomyositisLung Diseases, InterstitialInterferon-Induced Helicase, IFIH1AutoantibodiesHumansMaleFemaleSouth AfricaDisease ProgressionChildChild, Preschool

Stichwörter der Autor:innen

AfricaAnti-MDA5Juvenile dermatomyositisRapidly progressive interstitial lung disease

Substanzen

Interferon-Induced Helicase, IFIH1IFIH1 protein, humanAutoantibodies

Autor:innen und Institutionen

  • Department of Paediatric Rheumatology, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa.
  • Department of Paediatrics, Hospices Civils de Lyon, Lyon, France.
  • Chest and Allergy Centre, Christian Barnard Memorial Hospital, Cape Town, South Africa.
  • Department of Paediatric Pulmonary, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa.
  • Department of Paediatric Nephrology, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa.
  • Paediatric Intensive Care Unit, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa.

Förderung

  • University of Cape Town

Zitieren

APA

Lepage, M., Pereira, G., Akhalwaya, S., Gray, T., Zampoli, M., McCulloch, M., Nourse, P., Coetzee, A., Procter, C., Hlongwa, K., Pillay, T., & Webb, K. (2026). MDA5-associated juvenile dermatomyositis and interstitial lung disease from rapidly progressive to silent: a report of three cases in South African children and a review of the literature. Clinical Rheumatology, 45(7), 4635-4646. https://doi.org/10.1007/s10067-026-08070-6

Vancouver

Lepage M, Pereira G, Akhalwaya S, Gray T, Zampoli M, McCulloch M, et al. MDA5-associated juvenile dermatomyositis and interstitial lung disease from rapidly progressive to silent: a report of three cases in South African children and a review of the literature. Clinical Rheumatology. 2026;45(7):4635-4646. doi:10.1007/s10067-026-08070-6

BibTeX
@article{Lepage2026,
  author = {Lepage, Maurane and Pereira, Gabriella and Akhalwaya, Shehnaaz and Gray, Taryn and Zampoli, Marco and McCulloch, Mignon and Nourse, Peter and Coetzee, Ashton and Procter, Claire and Hlongwa, Khanyisile and Pillay, Tanyia and Webb, Kate},
  title = {MDA5-associated juvenile dermatomyositis and interstitial lung disease from rapidly progressive to silent: a report of three cases in South African children and a review of the literature},
  journal = {Clinical Rheumatology},
  year = {2026},
  volume = {45},
  number = {7},
  pages = {4635--4646},
  doi = {10.1007/s10067-026-08070-6}
}
Kostenlos starten →